• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

    5/20/25 8:52:00 AM ET
    $DGX
    Medical Specialities
    Health Care
    Get the next $DGX alert in real time by email

    Quest's second "Know Your Health" survey explores Americans' perceptions and priorities on their well-being in 2025

    Nearly one-third of Americans say their doctors/HCPs do not take the time to discuss preventive care and wellness with them; More than half of millennials, Gen Z cite barriers to accessing medical care

    SECAUCUS, N.J., May 20, 2025 /PRNewswire/ -- questhealth.com, the consumer-initiated testing platform from Quest Diagnostics (NYSE:DGX), one of the nation's leading providers of diagnostic information services, today revealed the results of its second "Know Your Health" survey, conducted online by The Harris Poll among nearly 2,100 U.S. adults. Findings revealed that most Americans are eager to take an active role in their healthcare journey, with 92% actively preparing for their future health and healthcare needs, but many experience barriers to receiving care, feel their doctors do not focus enough on preventive care and wellness discussions, and have gaps in knowledge on important personal health information.

    "For too long, Americans have been passive recipients of their healthcare and health information," says Richard Adams, Senior Vice President and General Manager, Consumer at Quest Diagnostics. "As the survey shows, many Americans are motivated to take charge of their health, but they may be experiencing barriers to accessing care through traditional channels and are unsure of where to go for support. At Quest, we're turning that traditional model on its head by giving people access to physician-guided diagnostic lab testing so they can proactively manage their health and feel empowered on their wellness journey."

    Prioritizing Personal Health in a World Dominated by Digital 

    In today's world of constant connectivity, it's surprising how often our own health stats fall by the wayside. In fact, the survey revealed that 2 in 5 Americans (40%) know their streaming platform passwords by heart, while only 19% know their cholesterol score. Cholesterol levels can be tested with a blood test, helping identify whether someone may be at risk of developing heart disease—insights that might not otherwise be known, as someone with high cholesterol does not always exhibit symptoms.

    Family medical history, which can help identify increased risk of certain hereditary conditions, seemed to be lower on the priority list for younger generations, with more than half of Gen Z ages 18-28 (56%) knowing their streaming platform passwords by heart compared to their family medical history (31%).

    "Family medical history and insights from laboratory testing help serve as a blueprint for one's health — it gives individuals and medical professionals clues to assess the likelihood of developing certain conditions, including heart disease, diabetes, and even some cancers, in the future," said Mark Kruzel, MD, Medical Director for questhealth.com. "As a physician, it concerns me that many individuals surveyed want to be healthy, but aren't aware of basic health risks, which can often be lowered with preemptive behaviors."

    Social media has also continued to be a driving force for Americans' health habits, with 1 in 4 Americans (24%) admitting they get advice about health topics from social media influencers. Furthermore, one-third (33%) of Americans have acknowledged seeking medical care or testing after seeing someone's personal health stories shared on social media, and that jumps to more than half for Gen Z (52%) and Millennials ages 29-44 (51%).

    The Power of Healthy Habits 

    After navigating the unique challenges that the COVID-19 pandemic presented, Americans seem to be back on track with their personal health. In fact, 7 in 10 Americans (70%) rate their current health as good (54%) or excellent (16%). In comparison, 3 in 10 Americans (30%) describe their current overall health as fair (26%) or poor (5%). Among Americans who describe their overall health as fair or poor, more than half believe stress (60%), poor sleep (55%), and lack of exercise (51%) are contributing to their current health, while 3 in 10 say loneliness/isolation (30%) is a contributing factor.

    When it comes to healthy habits that Americans view as a priority, sleep is king. In fact, 71% of Americans say that good sleep tops this list, followed by proper hydration (65%) and regular exercise (62%). More than half of Americans say they prioritize taking vitamins and supplements (59%), eating a well-balanced diet (54%), and going for an annual physical (53%). In regard to annual appointments and lab testing, nearly half of Americans say getting bloodwork done each year (47%) and keeping up with preventive screenings (45%) are a priority to them.

    Planning for a Healthier Future 

    "Planning for a healthy future is about making daily informed decisions that invest in your overall well-being. Diagnostic testing can help provide valuable insights to help guide us, together with our healthcare providers, on steps to manage our overall health. Our health is the foundation of everything we do, and the best time to start investing in it is today," said Dr. Kruzel.

    A compelling majority of Americans (92%) are actively preparing for their future health and healthcare needs. About 3 in 5 Americans are doing so by trying to stay physically active (60%) and attempting to maintain a healthy diet (57%). More specifically, Boomers ages 61-79 (67%) are more likely than Gen Z (45%) or Millennials (58%) to say they try to stay physically active to prepare for their future health/health care needs.

    Preventive care also plays a key role, with about half of Americans focusing on regular checkups and screenings (51%) and relying on advice from doctors and healthcare professionals (49%) to help them identify their potential health risks early on. More than a quarter (27%) also use health apps or wearables to track vital signs, activity levels, and/or sleep patterns to stay on top of their well-being and make lifestyle adjustments based on the data.

    Navigating the Healthcare Landscape

    While Americans say they are prioritizing healthy behaviors—and 31% are trying to stay informed about changes in healthcare policies that could impact them—they also cite challenges to accessing care.  More than 1 in 3 Americans (37%) say they experienced barriers to receiving medical care in the past 12 months, ranging from long waits for scheduling appointments (10%) and being unsure about insurance coverage (9%) to potential cost considerations of lab work (8%). Barriers increased significantly with each generation: 12% of Boomers, 30% of Gen X ages 45-60, 53% of Millennials, and 62% of Gen Z. Additionally, 30% of Americans agree their doctor/health care professional does not take the time to talk to them about prevention and wellness.

    The survey also explored Americans' understanding of alternative modes of accessing healthcare. As it stands, nearly 2 in 3 Americans (63%) do not know it is possible to purchase their own lab tests without a doctor's visit. As Americans continue to focus on their health, building awareness of this pathway can help broaden testing accessibility and help people gain a better understanding of insights that can impact their overall health.  

    Questhealth.com provides access to consumer-initiated lab testing ranging from comprehensive health panels and STD tests to hormone health panels and tests to help identify or monitor chronic disease. While individuals can purchase tests online without a prior doctor's visit, a third-party physician reviews all test requests and is available to review results and, for some conditions, provide a prescription for treatment.

    "Consumer-initiated lab testing through Quest makes the process simple for consumers by providing access to the same quality lab tests that doctors use and recommend by way of questhealth.com, with the benefit of physician-guided care," said Dr. Kruzel.

    For more information, please visit questhealth.com.

    Survey Methodology 

    This survey was conducted online within the United States by The Harris Poll on behalf of Quest Diagnostics from March 11-13, 2025, among 2,087 adults ages 18+. The sampling precision of Harris online polls is measured by using a Bayesian credible interval.  For this study, the sample data is accurate to within +/- 2.5 percentage points using a 95% confidence level. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact [email protected].

    About questhealth.com

    Quest empowers individuals with affordable, high-quality, trusted healthcare. The consumer-initiated test platform, questhealth.com, gives consumers more control over their own healthcare journeys, providing access to the same quality lab tests that doctors use and recommend, offering valuable information and insights about their health. questhealth.com offers more than 100 Quest Diagnostics lab tests in categories ranging from heart health and sexual health to allergies, fitness, and so much more. Tests available on questhealth.com also include physician oversight from an independent, third-party physician network, including test ordering and availability of a licensed physician to discuss test results. Consumers must be 18+ to purchase, and orders are not permitted in AK, AZ, or HI. For more information, please visit questhealth.com.

    About Quest Diagnostics

    Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

    questhealth.com logo

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/more-americans-know-their-streaming-platform-passwords-by-heart-than-their-cholesterol-score-new-survey-reveals-302460310.html

    SOURCE Quest Diagnostics

    Get the next $DGX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DGX

    DatePrice TargetRatingAnalyst
    4/2/2025$195.00Buy
    Redburn Atlantic
    3/4/2025$185.00Buy → Neutral
    Citigroup
    1/6/2025$169.00 → $174.00Market Perform → Outperform
    Leerink Partners
    12/17/2024$145.00 → $172.00Equal-Weight → Overweight
    Morgan Stanley
    12/10/2024$175.00 → $185.00Buy
    Jefferies
    10/23/2024$157.00 → $182.00Neutral → Outperform
    Robert W. Baird
    8/28/2024$165.00In-line
    Evercore ISI
    7/10/2024$145.00 → $165.00Neutral → Buy
    Citigroup
    More analyst ratings

    $DGX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Redburn Atlantic initiated coverage on Quest Diagnostics with a new price target

      Redburn Atlantic initiated coverage of Quest Diagnostics with a rating of Buy and set a new price target of $195.00

      4/2/25 8:51:11 AM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics downgraded by Citigroup with a new price target

      Citigroup downgraded Quest Diagnostics from Buy to Neutral and set a new price target of $185.00

      3/4/25 7:20:57 AM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Quest Diagnostics from Market Perform to Outperform and set a new price target of $174.00 from $169.00 previously

      1/6/25 7:49:06 AM ET
      $DGX
      Medical Specialities
      Health Care

    $DGX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Carter Robert B was granted 1,203 shares, increasing direct ownership by 81% to 2,685 units (SEC Form 4)

      4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)

      5/19/25 4:24:41 PM ET
      $DGX
      Medical Specialities
      Health Care
    • Director Diaz Luis was granted 1,203 shares, increasing direct ownership by 42% to 4,054 units (SEC Form 4)

      4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)

      5/19/25 4:24:09 PM ET
      $DGX
      Medical Specialities
      Health Care
    • Director Gregg Vicky B was granted 1,203 shares, increasing direct ownership by 7% to 18,138 units (SEC Form 4)

      4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)

      5/19/25 4:23:35 PM ET
      $DGX
      Medical Specialities
      Health Care

    $DGX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

      SECAUCUS, N.J., June 10, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to improve the assessment of elevated risk of cancer in individuals who would benefit from medically appropriate cancer screenings.  Under terms of the agreement, Quest will develop and validate a laboratory-developed blood test based on circulating protein biomarkers associated with high risk for one or more cancers, including colorectal,

      6/10/25 8:03:00 AM ET
      $DGX
      Medical Specialities
      Health Care
    • More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

      Quest's second "Know Your Health" survey explores Americans' perceptions and priorities on their well-being in 2025 Nearly one-third of Americans say their doctors/HCPs do not take the time to discuss preventive care and wellness with them; More than half of millennials, Gen Z cite barriers to accessing medical care SECAUCUS, N.J., May 20, 2025 /PRNewswire/ -- questhealth.com, the consumer-initiated testing platform from Quest Diagnostics (NYSE:DGX), one of the nation's leading providers of diagnostic information services, today revealed the results of its second "Know Your Health" survey, conducted online by The Harris Poll among nearly 2,100 U.S. adults. Findings revealed that most America

      5/20/25 8:52:00 AM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

      SECAUCUS, N.J., May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a presentation at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 11:00 a.m. Eastern Time. The presentation session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.

      5/16/25 1:11:00 PM ET
      $DGX
      Medical Specialities
      Health Care

    $DGX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Quest Diagnostics Incorporated (Amendment)

      SC 13G/A - QUEST DIAGNOSTICS INC (0001022079) (Subject)

      2/13/24 5:12:21 PM ET
      $DGX
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Quest Diagnostics Incorporated (Amendment)

      SC 13G/A - QUEST DIAGNOSTICS INC (0001022079) (Subject)

      1/25/24 12:16:40 PM ET
      $DGX
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Quest Diagnostics Incorporated (Amendment)

      SC 13G/A - QUEST DIAGNOSTICS INC (0001022079) (Subject)

      2/7/23 1:25:52 PM ET
      $DGX
      Medical Specialities
      Health Care

    $DGX
    Financials

    Live finance-specific insights

    See more

    $DGX
    SEC Filings

    See more
    • Quest Diagnostics Declares Quarterly Cash Dividend

      SECAUCUS, N.J., May 14, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.80 per share, payable on July 21, 2025 to shareholders of record of Quest Diagnostics common stock on July 7, 2025. About Quest DiagnosticsQuest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take acti

      5/14/25 6:17:00 PM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

      First quarter revenues of $2.65 billion, up 12.1% from 2024First quarter reported diluted earnings per share ("EPS") of $1.94, up 12.8% from 2024; and adjusted diluted EPS of $2.21, up 8.3% from 2024Full year 2025 reported diluted EPS now expected to be between $8.62 and $8.87; and adjusted diluted EPS is expected to remain between $9.55 and $9.80SECAUCUS, N.J., April 22, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leading provider of diagnostic information services, today announced financial results for the first quarter ended March 31, 2025. "In the fir

      4/22/25 6:43:00 AM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

      SECAUCUS, N.J., April 1, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2025 financial results on Tuesday, April 22, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.Q

      4/1/25 4:23:00 PM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - QUEST DIAGNOSTICS INC (0001022079) (Filer)

      5/22/25 6:28:25 AM ET
      $DGX
      Medical Specialities
      Health Care
    • SEC Form SCHEDULE 13G filed by Quest Diagnostics Incorporated

      SCHEDULE 13G - QUEST DIAGNOSTICS INC (0001022079) (Subject)

      5/14/25 10:45:25 AM ET
      $DGX
      Medical Specialities
      Health Care
    • SEC Form 144 filed by Quest Diagnostics Incorporated

      144 - QUEST DIAGNOSTICS INC (0001022079) (Subject)

      5/13/25 9:59:16 AM ET
      $DGX
      Medical Specialities
      Health Care

    $DGX
    Leadership Updates

    Live Leadership Updates

    See more
    • Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health

      Study to evaluate how behavioral and sensor data from wearables and blood tests can be leveraged to help individuals better assess and manage their metabolic health SECAUCUS, N.J., Jan. 17, 2024 /PRNewswire/ -- Fitbit and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced a collaboration to study the potential of wearable devices to improve metabolic health, which influences risk of developing several diseases, including diabetes and heart disease. The Wearables for Metabolic Health (WEAR-ME) pilot study will pair beh

      1/17/24 8:58:00 AM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics Board of Directors Elects James E. Davis Chairman of the Board

      SECAUCUS, N.J., March 3, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors elected James E. Davis, the company's Chief Executive Officer and President, to serve in the additional position of Chairman of the Board of Directors, effective April 1, 2023. "The Board carefully considered our governance structure and determined that combining the roles of Chairman and CEO under Jim Davis's leadership is in the best interest of shareholders to successfully continue to execute

      3/3/23 4:30:00 PM ET
      $DGX
      Medical Specialities
      Health Care
    • Quotient Limited Announces Appointment of Chief Financial Officer

      JERSEY, Channel Islands, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Company's Chief Financial Officer (CFO). Mr. Kiboro will assume the responsibilities of CFO on November 1st, 2021, replacing Mr. Peter Buhler who will support the Company during the transitional phase, as needed, before leaving Quotient Limited at year-end. "I am delighted to welcome Ali to the Executive team at this exciting time in our Company's evolution. He brings over 20 years of experience in global finance and has been a key driver of operational excellence in a career spanning healthcare services and manufacturing. I w

      10/12/21 8:45:00 AM ET
      $DGX
      $QTNT
      Medical Specialities
      Health Care
      Biotechnology: In Vitro & In Vivo Diagnostic Substances